The above results suggest that upregulation of KDM6B expression enhances CD8+ T-cell infiltration in colorectal tumor tissues and potentiates the therapeutic efficacy of immune checkpoint inhibitors. The gene discussed is CD8A; the disease is colorectal neoplasm.